Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
favipiravir (2 trials)
oseltamivir (tamiflu) (1 trial)
Critical Illness (Phase 2)
Hemorrhagic Fever, Ebola (Phase 2)
Influenza, Human (Phase 2)
Virus Diseases (Phase 2)
Trials (2 total)
Trial APIs (2 total)